drugset / Trial / NCT00929370
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to understand safety and tolerability of the drug GSK1018921 after 14 days of dosing in healthy volunteers and then in patient volunteers.
Timeline
- Start
- 2008-07
- Primary completion
- 2008-10
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK1018921 | Unknown | 80 mg | — |
| Subject | GSK1018921 | Unknown | 200 mg | — |